{"id":42147,"date":"2019-04-08T12:03:24","date_gmt":"2019-04-08T16:03:24","guid":{"rendered":"http:\/\/blogs.uakron.edu\/researchnewsinfo\/?p=42147"},"modified":"2019-04-08T12:03:24","modified_gmt":"2019-04-08T16:03:24","slug":"dod-vision-research-program-preannouncement","status":"publish","type":"post","link":"https:\/\/blogs.uakron.edu\/researchnewsinfo\/2019\/04\/08\/dod-vision-research-program-preannouncement\/","title":{"rendered":"DoD Vision Research Program Preannouncement"},"content":{"rendered":"\n<p style=\"text-align:center\"><strong>Defense Health Program<br>\nDepartment of Defense Vision Research Program<\/strong><\/p>\n\n\n\n<p><strong>Funding Opportunities for Fiscal Year\n2019 (FY19)<\/strong><\/p>\n\n\n\n<p><strong>The FY19 Defense\nAppropriation provides $20 million (M) to the Department of Defense Vision\nResearch Program (VRP)<\/strong>\nto support impactful\nmilitary-relevant vision research.&nbsp; As directed by the Office of\nthe Assistant Secretary of Defense for Health Affairs, the Defense Health\nAgency J9, Research and Development Directorate manages the Defense Health\nProgram (DHP) Research, Development, Test, and Evaluation (RDT&amp;E) appropriation.\n&nbsp;The managing agent for the anticipated Program Announcements\/Funding\nOpportunities is the Congressionally Directed Medical Research Programs (CDMRP)\nat the U.S. Army Medical Research and Materiel Command (USAMRMC).<\/p>\n\n\n\n<p>The VRP is providing the\ninformation in this pre-announcement to allow investigators time to plan and\ndevelop applications.&nbsp; FY19 VRP Program Announcements and General\nApplication Instructions for the following award mechanisms are anticipated to\nbe posted on the Grants.gov website in May 2019. &nbsp;Pre-application and\napplication deadlines will be available when the Program Announcements are\nreleased.&nbsp; This pre-announcement should not be construed as an obligation\nby the government.<\/p>\n\n\n\n<p>Applications submitted to\nthe FY19 VRP must address at least one of the following Focus Areas: <\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Eye injury or visual dysfunction as related to a military-relevant traumatic      event.\u00a0 Examples of military-relevant trauma may include, but are not limited to:<ul><li>Blast, blunt, thermal, or chemical trauma<\/li><\/ul><ul><li>Trauma caused by directed energy weapons such as laser, microwaves, and particle beams<\/li><\/ul><\/li><li>Diagnosis and treatment of eye injuries in austere environments and prolonged field care settings<\/li><\/ul>\n\n\n\n<p><strong>Focused\nTranslational Team Science Award (FTTSA)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Overall\nLead Principal Investigator (PI) must be an independent investigator at or\nabove the level of Associate Professor (or equivalent) with experience in\ndeveloping and running large-scale initiatives.<\/li><li>Leaders\nof individual projects may be independent investigators at all academic levels\n(or equivalent).<\/li><\/ul>\n\n\n\n<p><em><strong>Preproposal is required; application submission\nis by invitation only.<\/strong><\/em> <\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Supports a team initiative that leverages the strengths of\ninvestigators specializing in different fields to address an overarching\nscientific challenge or question and fundamentally advance the understanding\nand treatment of military-relevant vision trauma.<\/li><li><strong>Overarching Challenge<\/strong><\/li><\/ul>\n\n\n\n<p>Investigators\nare encouraged to:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Consider\nbarrier(s) to and\/or gap(s) in the understanding, prevention, diagnosis,\nmitigation, and\/or treatment of eye injury or visual dysfunction associated\nwith a military-relevant trauma and envision what may be achievable in 10 to 15\nyears.<\/li><li>Identify,\nbased on the long-term vision, what should and can be achieved in the near\nterm. <\/li><li>Design\nprojects and research teams around these considerations.<\/li><li><strong>Research Projects<\/strong><\/li><li>The\nteam science proposal shall include at least three (3) but no more than five\n(5) distinct research projects that together form a concerted and synergistic\neffort that advances a solution beyond what would be possible through\nindividual efforts.<\/li><li>Preliminary\ndata to support the feasibility of each project are required. <\/li><li>May\ninclude, as a portion of the proposed research, a pilot clinical trial\ncomponent that collects preliminary data to support the feasibility, rationale,\nand design of subsequent clinical trials.<\/li><li><strong>Research Team<\/strong><\/li><li>The\noverall lead PI must have demonstrated success in leading large collaborative\nresearch projects.<\/li><li>The\noverall lead PI must devote a minimum of 20% effort.<\/li><li>Project\nleader of each of the complementary and synergistic research projects must be\nan independent investigator with strong qualifications.<\/li><\/ul>\n\n\n\n<ul class=\"wp-block-list\"><li>Must have a\n     detailed <strong>Implementation Plan<\/strong> for participating research groups to\n     coordinate efforts, facilitate collaboration, and create synergy<\/li><li>Maximum funding of\n     <strong>$5,000,000<\/strong> for direct costs (plus indirect costs) <\/li><li>The maximum period of performance is <strong>4&nbsp;<\/strong>years.\n     <\/li><\/ul>\n\n\n\n<p><strong>Investigator-Initiated\nResearch Award (IIRA)<\/strong><\/p>\n\n\n\n<p>Independent\ninvestigators at all academic levels (or equivalent).<\/p>\n\n\n\n<p><em><strong>Preproposal is required; application submission\nis by invitation only.<\/strong><\/em>\n<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Supports\nstudies that will yield highly impactful discoveries or major advancements in\nresearch and\/or patient care.<\/li><li><strong>Funding Level 1<\/strong> supports exploratory, high-risk\/high-reward\nresearch in the earliest stages of development. <\/li><li>Research\nmust have the potential to yield new avenues of investigation, such as new\napproaches, new research tools, or new paradigms.<\/li><li>While\nno preliminary data is required, applicants must provide solid rationale of the\nresearch idea.&nbsp; The investigating team must have sufficient expertise to\ntest the idea.<\/li><li>Applications\nin the following areas are encouraged:<\/li><li>Pathobiology\nunderlying TBI-associated visual dysfunction<\/li><li>Assessment,\ndiagnosis, or treatment in prolonged field care settings<\/li><li>Mechanism\nof injury for visual system trauma secondary to directed energy<\/li><li><strong>Funding Level 2<\/strong> supports the advancement of more mature\nresearch that has the potential to make significant advancements toward\nclinical translation. <\/li><li>Preliminary\ndata supporting the readiness and feasibility of the proposed research is\nrequired.&nbsp; <\/li><li>PI\nis responsible for selecting the funding level that is most appropriate for the\nresearch proposed.&nbsp; The funding level should be selected based on the\nstage of the research project, rather than the amount of the budget.<\/li><li>Clinical\ntrials are not allowed<\/li><\/ul>\n\n\n\n<p><strong>Funding\nLevel 1: <\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Maximum\nfunding of <strong>$260,000<\/strong> for direct costs (plus indirect costs) <\/li><li>The\nmaximum period of performance is <strong>2&nbsp;<\/strong>years. <\/li><\/ul>\n\n\n\n<p><strong><br>\nFunding Level 2: <\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Maximum\nfunding of <strong>$500,000<\/strong> for direct costs (plus indirect costs) <\/li><li>The\nmaximum period of performance is <strong>3<\/strong>&nbsp;years. <\/li><\/ul>\n\n\n\n<p><strong>Translational\nResearch Award (TRA)<\/strong><\/p>\n\n\n\n<p>Independent\ninvestigators at all academic levels (or equivalent).<\/p>\n\n\n\n<p><em><strong>Preproposal is\nrequired; application submission is by invitation only.<\/strong><\/em> <\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Supports\ntranslational research that moves promising laboratory research into clinical\napplications.<\/li><li>It\nis expected that an IND or IDE application will be submitted during or by the\nend of the period of performance.<\/li><li>Expansion\nof a highly impactful research project that was previously funded through a VRP\nfunding opportunity is encouraged but not required.<\/li><li>Preliminary\ndata required. <\/li><li>May\ninclude, as a portion of the proposed research, a pilot clinical trial\ncomponent that collects preliminary data to support the feasibility, rationale,\nand design of subsequent clinical trials.<\/li><li>Maximum\nfunding of <strong>$750,000<\/strong> for direct costs (plus indirect costs) <\/li><li>The\nmaximum period of performance is <strong>3&nbsp;<\/strong>years <\/li><\/ul>\n\n\n\n<p>A pre-application is\nrequired and must be submitted through the electronic Biomedical Research\nApplication Portal (eBRAP) at <a href=\"https:\/\/nam03.safelinks.protection.outlook.com\/?url=https%3A%2F%2Febrap.org%2F&amp;data=02%7C01%7CRschSrvsGA8%40uakron.edu%7Cc52e1b9fb66647e3040b08d6b9e77c7f%7Ce8575dedd7f94ecea4aa0b32991aeedd%7C1%7C0%7C636900801214008896&amp;sdata=ndMEl5at10BihQDrkivJcGLGukGtpMPW%2FrHIGrMK0l8%3D&amp;reserved=0\">https:\/\/eBRAP.org<\/a> prior to the pre-application\ndeadline.&nbsp; All applications must conform to the final Program Announcements\nand General Application Instructions that will be available for electronic\ndownloading from the Grants.gov website.&nbsp; The application package\ncontaining the required forms for each award mechanism will also be found on\nGrants.gov.&nbsp; A listing of all CDMRP and other USAMRMC extramural funding\nopportunities can be obtained on the Grants.gov website by performing a basic\nsearch using CFDA Number 12.420.&nbsp; <\/p>\n\n\n\n<p>Submission deadlines are\nnot available until the Program Announcements are released. &nbsp;For email notification when Program Announcements are\nreleased, subscribe to program-specific news and updates under \u201cEmail\nSubscriptions\u201d on the eBRAP homepage at <a href=\"https:\/\/nam03.safelinks.protection.outlook.com\/?url=https%3A%2F%2Febrap.org%2F&amp;data=02%7C01%7CRschSrvsGA8%40uakron.edu%7Cc52e1b9fb66647e3040b08d6b9e77c7f%7Ce8575dedd7f94ecea4aa0b32991aeedd%7C1%7C0%7C636900801214018901&amp;sdata=H0l9%2F5xYVd%2B0VEXhUSvhAwwWNQZnWyD1DWldNn6Cb10%3D&amp;reserved=0\">https:\/\/ebrap.org\/<\/a>.&nbsp; For more information about the\nVRP or other CDMRP-administered programs, please visit the <a href=\"https:\/\/nam03.safelinks.protection.outlook.com\/?url=http%3A%2F%2Fcdmrp.army.mil&amp;data=02%7C01%7CRschSrvsGA8%40uakron.edu%7Cc52e1b9fb66647e3040b08d6b9e77c7f%7Ce8575dedd7f94ecea4aa0b32991aeedd%7C1%7C0%7C636900801214018901&amp;sdata=TMaJAnxPu3x4EszqBR2%2FehrJSYHa8tKdizzU9g0%2BQ28%3D&amp;reserved=0\">CDMRP website<\/a> (<a href=\"https:\/\/nam03.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fcdmrp.army.mil&amp;data=02%7C01%7CRschSrvsGA8%40uakron.edu%7Cc52e1b9fb66647e3040b08d6b9e77c7f%7Ce8575dedd7f94ecea4aa0b32991aeedd%7C1%7C0%7C636900801214028910&amp;sdata=9H%2Bit7uvDiqpPK1Cl7YT1i%2Fdq0cMr0CsAIhvuAZ8ht4%3D&amp;reserved=0\">https:\/\/cdmrp.army.mil<\/a>).<\/p>\n\n\n\n<p><strong>Point of Contact:<\/strong> <\/p>\n\n\n\n<p>CDMRP Public Affairs <br>\n301-619-9783 <br>\n<strong><a href=\"mailto:usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil\">usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Defense Health Program Department of Defense Vision Research Program Funding Opportunities for Fiscal Year 2019 (FY19) The FY19 Defense Appropriation provides $20 million (M) to the Department of Defense Vision Research Program (VRP) to support impactful military-relevant vision research.&nbsp; As &hellip; <a href=\"https:\/\/blogs.uakron.edu\/researchnewsinfo\/2019\/04\/08\/dod-vision-research-program-preannouncement\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":3755,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-42147","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/blogs.uakron.edu\/researchnewsinfo\/wp-json\/wp\/v2\/posts\/42147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.uakron.edu\/researchnewsinfo\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.uakron.edu\/researchnewsinfo\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.uakron.edu\/researchnewsinfo\/wp-json\/wp\/v2\/users\/3755"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.uakron.edu\/researchnewsinfo\/wp-json\/wp\/v2\/comments?post=42147"}],"version-history":[{"count":1,"href":"https:\/\/blogs.uakron.edu\/researchnewsinfo\/wp-json\/wp\/v2\/posts\/42147\/revisions"}],"predecessor-version":[{"id":42151,"href":"https:\/\/blogs.uakron.edu\/researchnewsinfo\/wp-json\/wp\/v2\/posts\/42147\/revisions\/42151"}],"wp:attachment":[{"href":"https:\/\/blogs.uakron.edu\/researchnewsinfo\/wp-json\/wp\/v2\/media?parent=42147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.uakron.edu\/researchnewsinfo\/wp-json\/wp\/v2\/categories?post=42147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.uakron.edu\/researchnewsinfo\/wp-json\/wp\/v2\/tags?post=42147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}